David Gomez Lamarca

Title: David Gomez Lamarca: Innovator in Particle Size Stabilization

Introduction

David Gomez Lamarca is a notable inventor based in Castellbisbal-Barcelona, Spain. He has made significant contributions to the field of pharmaceutical sciences, particularly in the stabilization of particle sizes for medicinal compounds.

Latest Patents

David holds a patent for a process that stabilizes the particle size of micronized glycopyrronium salt, specifically glycopyrronium bromide. This innovative process results in a micronized product that exhibits enhanced chemical and polymorphic stability, even after extended storage periods. The patent also encompasses compositions that include the stabilized glycopyrronium salt, as well as dry powder inhaler devices and capsules or blisters containing the stabilized compound. The applications of this invention are particularly relevant in treating conditions such as asthma, chronic obstructive pulmonary disease, and cystic fibrosis.

Career Highlights

David is currently associated with Inke, S.A., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the pharmaceutical industry, focusing on improving the efficacy and stability of medicinal products.

Collaborations

David collaborates with esteemed colleagues, including Josep Terradas Camins and Josep Maria Carulla Oliver. Their combined expertise contributes to the innovative projects at Inke, S.A.

Conclusion

David Gomez Lamarca's contributions to particle size stabilization represent a significant advancement in pharmaceutical technology. His work not only enhances the stability of important medications but also improves treatment options for patients with respiratory diseases.